Argentina must eliminate restrictive patentability guidelines to drive innovation and access
October 23, 2024In the 12 years since Argentina issued patentability guidelines for biopharmaceutical products, we have seen the drawbacks of restricting innovators, which only underscores the importance of promoting strong intellectual property protections. Read why it’s time to eliminate the guidelines for the benefit of Argentina and its people.